PERSPECTA

News from every angle

Back to headlines

Regenxbio Shares Climb Following Positive Duchenne Trial Results

Regenxbio's shares have increased after the company announced positive results from its Duchenne trial.

14 May, 14:09 — 14 May, 14:09
PostShare

Sources

Showing 1 of 1 sources